Arun Srivastava focuses on Molecular biology, Virology, Transduction, Genetic enhancement and Adeno-associated virus. His Molecular biology research is multidisciplinary, relying on both Haematopoiesis, Stem cell, Gene expression, Tyrosine kinase and Adeno-Associated Virus Type 2. His study in Virology is interdisciplinary in nature, drawing from both Myeloid and Recombinant DNA.
His Transduction study integrates concerns from other disciplines, such as Cell culture, Tyrosine, Transgene, Mutant and Cell biology. His Genetic enhancement research integrates issues from Cytotoxic T cell, Heterologous and In vivo. His Adeno-associated virus research includes elements of Reporter gene and FGF10.
His primary areas of investigation include Molecular biology, Transduction, Virology, Surgery and Genetic enhancement. The concepts of his Molecular biology study are interwoven with issues in Cell culture, Adeno-associated virus, Gene, Phosphorylation and Adeno-Associated Virus Type 2. The study incorporates disciplines such as Tyrosine, Haematopoiesis, Transgene, Cell biology and In vivo in addition to Transduction.
DNA is closely connected to Recombinant DNA in his research, which is encompassed under the umbrella topic of Virology. The various areas that Arun Srivastava examines in his Surgery study include Incidence and Myelopathy. His Genetic enhancement study combines topics from a wide range of disciplines, such as Viral vector, Stem cell and Gene expression.
The scientist’s investigation covers issues in Surgery, Radiology, Virus, Genetic enhancement and Anatomy. In his research on the topic of Surgery, Trigeminal neuralgia is strongly related with Incidence. His Virus study deals with the bigger picture of Virology.
The study of Virology is intertwined with the study of Adeno-associated virus in a number of ways. His work in Genetic enhancement is not limited to one particular discipline; it also encompasses Cell biology. The Capsid study combines topics in areas such as Recombinant DNA and Transduction.
Arun Srivastava spends much of his time researching Surgery, Genetic enhancement, Virus, Capsid and Histopathology. His study in Genetic enhancement is interdisciplinary in nature, drawing from both Transduction and Cell biology. His Virus study contributes to a more complete understanding of Virology.
He works in the field of Virology, focusing on Serotype in particular. Arun Srivastava combines subjects such as Computational biology, Recombinant DNA and Gene delivery with his study of Capsid. His studies deal with areas such as Human liver, Clinical efficacy, Gene transfer and Adeno-associated virus as well as Parvovirus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
Arun Srivastava;Keyun Qing;Cathryn Mah;Jonathan Hansen.
Nature Medicine (1999)
Nucleotide sequence and organization of the adeno-associated virus 2 genome.
A Srivastava;E W Lusby;K I Berns.
Journal of Virology (1983)
Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses.
Li Zhong;Baozheng Li;Cathryn S. Mah;Lakshmanan Govindasamy.
Proceedings of the National Academy of Sciences of the United States of America (2008)
Impact, Diagnosis and Treatment of von Willebrand Disease*
J E Sadler;P M Mannucci;Erik Berntorp;N Bochkov.
Thrombosis and Haemostasis (2000)
High-efficiency Transduction of the Mouse Retina by Tyrosine-mutant AAV Serotype Vectors
Hilda Petrs-Silva;Astra Dinculescu;Qiuhong Li;Seok-Hong Min.
Molecular Therapy (2009)
The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study.
F Rodeghiero;G Castaman;A Tosetto;J Batlle.
Journal of Thrombosis and Haemostasis (2005)
Rescue of adeno-associated virus from recombinant plasmids: Gene correction within the terminal repeats of AAV
Richard J. Samulski;Arun Srivastava;Kenneth I. Berns;Nicholas Muzyczka.
Safe vector for gene therapy
Adeno-associated virus 2 co-receptors?-first reply
Keyun Qing;Jonathan Hansen;Arun Srivastava.
Nature Medicine (1999)
α5β1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of β1 integrin for viral entry
Kirsten A. Weigel-Kelley;Mervin C. Yoder;Arun Srivastava.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: